Search Results - "Pfeiffer, Per"

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study.

Authors: Eriksen, Martina Pfeiffer, Per Rohrberg, Kristoffer Staal et al.

Source: BMC Cancer. 12/19/2022, Vol. 22 Issue 1, p1-6. 6p.

Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One‐Bag Protocols.

Authors: Rasmussen, Trine Holm Mortz, Charlotte Gotthard Pfeiffer, Per et al.

Source: Clinical & Translational Allergy. Aug2025, Vol. 15 Issue 8, p1-12. 12p.

Do we make progress in elderly patients with metastatic colorectal cancer?

Authors: Glimelius, Bengt Pfeiffer, Per

Source: Acta Oncologica. Nov2018, Vol. 57 Issue 11, p1422-1426. 5p.

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.

Authors: Larsen, Finn Ole Pfeiffer, Per Nielsen, Dorte et al.

Source: Acta Oncologica. Jun2011, Vol. 50 Issue 4, p574-577. 4p. 3 Charts, 1 Graph.

Why are some patients in treatment for advanced cancer reluctant to consult their GP?

Authors: Aabom, Birgit Pfeiffer, Per

Source: Scandinavian Journal of Primary Health Care. Mar2009, Vol. 27 Issue 1, p58-62. 5p.

Subjects: Cancer patients, Cancer treatment, General practitioners, Perspective (Philosophy), Interviewing

Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil.

Authors: Pfeiffer, Per Nielsen, Dorte Yilmaz, Mette et al.

Source: Acta Oncologica. Jul2007, Vol. 46 Issue 5, p697-701. 5p. 3 Charts, 2 Graphs.

High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial.

Authors: Pfeiffer, Per¹ Per.Pfeiffer@ouh.fyns-amt.dk.

Source: Acta Oncologica. May2005, Vol. 44 Issue 3, p224-229. 6p.

Short-Time Infusion of Oxaliplatin (Eloxatin®) in Combination with Capecitabine (Xeloda®) in Patients with Advanced Colorectal Cancer.

Authors: Pfeiffer, Per Hahn, Pernille Jensen, Helle Anita

Source: Acta Oncologica. Dec2003, Vol. 42 Issue 8, p832-836. 5p.

Dual Modulation of UFT with Leucovorin and Hydroxyurea in Metastatic Colorectal Cancer.

Authors: Jakobsen, Anders Pfeiffer, Per Hansen, Flemming et al.

Source: Acta Oncologica. 2001, Vol. 40 Issue 1, p63-66. 4p. 2 Charts, 2 Graphs.

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.

Authors: Pfeiffer, Per Yilmaz, Mette Möller, Sören et al.

Source: Lancet Oncology. Mar2020, Vol. 21 Issue 3, p412-420. 9p.

Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies.

Authors: Tarpgaard, Line Schmidt Winther, Stine Brændegaard Pfeiffer, Per

Source: Cancers. Jan2024, Vol. 16 Issue 1, p126. 15p.

The Role of Inflammatory Biomarkers in PIPAC: Predicting Survival and Treatment Completion in Patients with Peritoneal Metastasis.

Authors: Roensholdt, Signe Graversen, Martin Detlefsen, Sönke et al.

Source: Journal of Cancer. 2026, Vol. 17 Issue 1, p10-20. 11p.

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.

Authors: Chen, Inna M. Johansen, Astrid Z. Dehlendorff, Christian et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jan2020, Vol. 29 Issue 1, p176-184.

It’s time to move forward in geriatric oncology.

Authors: Lembrecht Jørgensen, Trine Pfeiffer, Per

Source: Acta Oncologica. Jan2016, Vol. 55 Issue 1, p1-2. 2p.

Information provision to older patients receiving palliative chemotherapy: a quality study.

Authors: Lindhardt, Christina Louise Winther, Stine Brændegaard Pfeiffer, Per et al.

Source: BMJ Supportive & Palliative Care. 2024 Supplement, Vol. 14, pe2664-e2670. 7p.

Clinical Trial Enrollment, Patient Characteristics, and Survival Differences in Prospectively Registered Metastatic Colorectal Cancer Patients.

Authors: Sorbye, Halfdan Pfeiffer, Per Cavalli-Björkman, Nina et al.

Source: Cancer (0008543X). 10/15/2009, Vol. 115 Issue 20, p4679-4687. 9p.

KRAS^G12C inhibition in colorectal cancer.

Authors: Pfeiffer, Per Qvortrup, Camilla

Source: Lancet Oncology. Jan2022, Vol. 23 Issue 1, p10-11. 2p.

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis

Authors: Offersen, Birgitte Vrou Pfeiffer, Per Andreasen, Peter et al.

Source: Lung Cancer (01695002). Apr2007, Vol. 56 Issue 1, p43-50. 8p.

Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

Authors: Nielsen, Dorte L. Pfeiffer, Per Jensen, Benny Vittrup

Source: Acta Oncologica. Dec2006, Vol. 45 Issue 8, p1137-1138. 2p. 1 Chart.

Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma.

Authors: Iden, Cecilie Riis Øgaard, Nadia Mustafa, Salah Mohammad et al.

Source: Gastric Cancer. Jul2026, Vol. 29 Issue 4, p798-807. 10p.